Skip to main content
Caplight Logo









Citadel Discovery

Citadel Discovery

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://www.citadeldiscovery.io/

Last Round

Accelerator

Dec 8, 2022

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Citadel Discovery is a biotechnology company that provides an AI-driven platform for drug discovery, leveraging DNA-encoded libraries and computational methods to accelerate the development of therapeutics.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, ML Platforms, Medical AI

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting

AI Layer

Infrastructure

Keywords

drug discoveryDNA-encoded librariesDELAI drug discoverysmall-molecule discoverysynthetic datain silico drug discoveryproteomics datamachine learning modelsdata as a serviceDaaSbiotech AIlead optimizationmolecular designtech bio

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Citadel Discovery Comparables

Compare Citadel Discovery with similar companies based on industry and business-model similarity.

Citadel Discovery comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Leash Bio
91%
Relay Therapeutics
77%
1910 Genetics
77%

Citadel Discovery Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorDec 8, 2022

Citadel Discovery Investors

Notable investors and investment history

Citadel Discovery investors
InvestorRounds
PharmStarsAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2026

    Monthly visitors grew 246% MoM, from 242 to 837.

  • Mar 4, 2026

    Monthly visitors grew 3115% MoM, from 26 to 836.

Citadel Discovery Filings

Explore SEC and related filing metadata, where available.

Citadel Discovery filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Citadel Discovery's valuation, stock price, and market status.

Is Citadel Discovery a public or private company?

Citadel Discovery is a private company.

What is the current stock price of Citadel Discovery?

Citadel Discovery is a private company, so its shares have no public market price. Caplight tracks Citadel Discovery's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Citadel Discovery worth (valuation)?

Valuation information for Citadel Discovery is not publicly available.

Can I buy Citadel Discovery stock?

Citadel Discovery shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Citadel Discovery's last funding round?

Citadel Discovery's most recent funding round was Accelerator on December 8, 2022.

Who are the main investors in Citadel Discovery?

Key investors in Citadel Discovery include PharmStars.

Will Citadel Discovery IPO soon?

No public IPO plans have been announced for Citadel Discovery.

How can I track Citadel Discovery secondary market activity?

Caplight tracks bids, offers, and trades in Citadel Discovery's shares on secondary markets.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range1
Year Founded2021
Last FundingDec 8, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?